ALBANJI MH, SURBAYA SH, ALNAKHLI OA. IMMUNOPATHOGENESIS AND EMERGING IMMUNOTHERAPIES IN TYPE 1 DIABETES MELLITUS: THE ROLE OF TEPLIZUMAB IN DISEASE MODULATION. TPM [Internet]. 2025 Aug. 11 [cited 2025 Nov. 13];32(S1 (2025): Posted 12 May):738-44. Available from: https://tpmap.org/submission/index.php/tpm/article/view/249